Somatrogon Pen Injector [Ngenla]
RxNorm 2644522

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2644522 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: somatrogon Pen Injector [Ngenla].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDF
Somatrogon Pen Injector [Ngenla]
AUI:12827268
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDFPrescribable

Semantic Branded Drug Form (SBDF):
Somatrogon Pen Injector [Ngenla]
(Atom ID: 12827268)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
somatrogon Pen Injector [Ngenla]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2644522
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12827268
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDF
Semantic Branded Drug Form (Ingredient + Dose Form + Brand Name)
Source Code
2644522
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Somatrogon-ghla injection


Somatrogon-ghla injection is used to replace growth hormone (a natural hormone produced by your body) and to increase growth in children 3 years of age or older with growth hormone deficiency. Somatrogon-ghla is a human growth hormone (hGH) analog. It works by replacing growth hormones that are normally produced in the body.
[Learn More]


* Please review the disclaimer below.